Arkolith/Insider Trading/GMED/Form 4

Paul David C

Executive Chairman, Director, 10% OwnerGLOBUS MEDICAL INC (GMED) · full profile →Form 4 · filed Nov 20, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2024Option exercise(M)26K$24.10$628K26K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 15, 2024Option exercise(M)26K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-129270) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML